Trial no.:
|
PACTR202001862833093 |
Date of Approval:
|
14/01/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Efficacy of A multi-modal Approach in Management of Patients with Upper Crossed Syndrome: A randomized Controlled Trial |
Official scientific title |
Efficacy of A multi-modal Approach in Management of Patients with Upper Crossed Syndrome: A randomized Controlled Trial |
Brief summary describing the background
and objectives of the trial
|
Upper crossed syndrome (UCS) is a combination of a forward head posture (FHP) and forward shoulder posture (FSP) associated with cervical hyperlordosis, thoracic hyperkyphosis, protraction and elevation of both shoulders and internal rotation, abduction and winging of the scapulae. UCS represents an important health problem in many industrialized countries and is considered as one of the work related musculoskeletal disorders as it leads to a large number of days lost and it’s related workers compensation and disability payments. The technological advancement and popularization of computers and jobs that compel subjects to lean forward or assume a slouched posture for prolonged period of time are the causes UCS. UCS might lead to multitude of dysfunctions all over the body. So finding an effective treatment for UCS is very important. There is a lack of well-designed randomized controlled trails to investigate the efficacy of rehabilitation of UCS. Thus, to date the ideal manual physical therapy approach to treat UCS has not been identified. So the objective of this study is to investigate the efficacy of a multi-modal approach which includes a combination of MET, cervical and scapulothoracic stabilization exercises and postural correction training with advice on patients with UCS. A pilot study will be conducted to calculate sample size. The subjects of both genders with age ranging from 30 to 60 will be allocated randomly into two equal groups A & B. Outcome measures will include: Craniovertebral angle (CVA) and Sagittal shoulder angle (SSA) will be measured by photogrammetry, Pain intensity will be measured by Visual analogue scale (VAS) and functional status will be measured by Neck disability index (NDI) will be done before and after treatment. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
UCS FHP FSP MET CVA SSA VAS NDI |
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
20/12/2019 |
Actual trial start date |
|
Anticipated date of last follow up |
01/03/2020 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|